Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2426-2435
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2426
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2426
Figure 3 Independent significant factors of medium and long-term survival based on direct surgical resection.
A: Patients older than 45 years old had a longer overall survival (OS) than patients younger than 45 years old who underwent direct surgical resection (P = 0. 029); B: Patients without ascites had a longer overall OS than those with ascites who underwent direct surgical resection (P = 0.016); C: Patients older than 45 years old had longer OS after ovarian metastasis than those younger than 45 years old (P = 0.044); D: Patients without ascites had longer OS after ovarian metastasis than patients with ascites who underwent direct surgical resection (P = 0.006); E: Patients without ascites had longer postoperative disease-free survival than patients with ascites who underwent direct surgical resection (P = 0.004); F: Patients without ascites had longer postoperative OS than those with ascites who underwent direct surgical resection (P = 0.003); G: Patients with carbohydrate antigen 125 > 26.1 had a longer postoperative OS than those with carbohydrate antigen 125 < 26.1 who underwent direct surgical resection (P = 0.046). CA125: Carbohydrate antigen 125.
- Citation: Yan HP, Lu HR, Zhang YX, Yang L, Chen ZL. Surgical resection and neoadjuvant therapy in patients with gastric cancer and ovarian metastasis: A real-world study. World J Gastrointest Surg 2024; 16(8): 2426-2435
- URL: https://www.wjgnet.com/1948-9366/full/v16/i8/2426.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i8.2426